Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pyxis Oncology, Inc. | 918,308 | reported | 31 Mar 2025 | tx 19+7,465,518−1,273,586 |
| Opus Genetics, Inc. | 3,537 | reported | 06 Jun 2019 | tx 2+88,505 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Mar 2025 | GRANT_AWARD | Pyxis Oncology, Inc. | 918,308 | 0.98 USD | deriv |
| 23 Dec 2024 | GRANT_AWARD | Pyxis Oncology, Inc. | 1,135,000 | 0.00 USD | deriv |
| 26 Mar 2024 | GRANT_AWARD | Pyxis Oncology, Inc. | 1,071,242 | 3.83 USD | deriv |
| 14 Sept 2023 | SALE | Pyxis Oncology, Inc. | 100 | 2.25 USD | |
| 18 Sept 2023 | SALE | Pyxis Oncology, Inc. | 8,541 | 2.10 USD | |
| 13 Sept 2023 | SALE | Pyxis Oncology, Inc. | 3,000 | 2.27 USD | |
| 13 Sept 2023 | TAX_WITHHOLDING | Pyxis Oncology, Inc. | 184,742 | 2.13 USD | |
| 11 Sept 2023 | SALE | Pyxis Oncology, Inc. | 20,000 | 2.27 USD | |
| 12 Sept 2023 | SALE | Pyxis Oncology, Inc. | 4,917 | 2.25 USD | |
| 07 Sept 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 469,483 | 0.00 USD | |
| 24 Mar 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 703,379 | 0.00 USD | |
| 24 Mar 2023 | OTHER | Pyxis Oncology, Inc. | 990,461 | — | deriv |
| 24 Mar 2023 | OTHER | Pyxis Oncology, Inc. | 61,825 | — | deriv |
| 24 Mar 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 990,461 | — | deriv |
| 24 Mar 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 61,825 | — | deriv |
| 03 Jan 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 95,684 | 0.00 USD | |
| 14 Apr 2022 | GRANT_AWARD | Pyxis Oncology, Inc. | 315,273 | 0.00 USD | |
| 31 Mar 2022 | GRANT_AWARD | Pyxis Oncology, Inc. | 742,574 | 0.00 USD | |
| 07 Oct 2021 | GRANT_AWARD | Pyxis Oncology, Inc. | 962,289 | 0.00 USD | deriv |
| 06 Jun 2019 | GRANT_AWARD | Opus Genetics, Inc. | 3,537 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | Opus Genetics, Inc. | 84,968 | 0.00 USD | deriv |